These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 7505365

  • 1. Pharmacology of SC-52458, an orally active, nonpeptide angiotensin AT1 receptor antagonist.
    Olins GM, Corpus VM, Chen ST, McMahon EG, Palomo MA, McGraw DE, Smits GJ, Null CL, Brown MA, Bittner SE.
    J Cardiovasc Pharmacol; 1993 Oct; 22(4):617-25. PubMed ID: 7505365
    [Abstract] [Full Text] [Related]

  • 2. In vitro pharmacology of a nonpeptidic angiotensin II receptor antagonist, SC-51316.
    Olins GM, Corpus VM, McMahon EG, Palomo MA, Schuh JR, Blehm DJ, Huang HC, Reitz DB, Manning RE, Blaine EH.
    J Pharmacol Exp Ther; 1992 Jun; 261(3):1037-43. PubMed ID: 1602371
    [Abstract] [Full Text] [Related]

  • 3. Pharmacology of DuP 532, a selective and noncompetitive AT1 receptor antagonist.
    Wong PC, Hart SD, Chiu AT, Herblin WF, Carini DJ, Smith RD, Wexler RR, Timmermans PB.
    J Pharmacol Exp Ther; 1991 Nov; 259(2):861-70. PubMed ID: 1941632
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018.
    Kushida H, Nomura S, Morita O, Harasawa Y, Suzuki M, Nakano M, Ozawa K, Kunihara M.
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1042-53. PubMed ID: 7562467
    [Abstract] [Full Text] [Related]

  • 5. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, SK&F 108566.
    Edwards RM, Aiyar N, Ohlstein EH, Weidley EF, Griffin E, Ezekiel M, Keenan RM, Ruffolo RR, Weinstock J.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):175-81. PubMed ID: 1309870
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological effects of GR138950, a novel angiotensin AT1 receptor antagonist.
    Hilditch A, Hunt AA, Travers A, Polley J, Drew GM, Middlemiss D, Judd DB, Ross BC, Robertson MJ.
    J Pharmacol Exp Ther; 1995 Feb; 272(2):750-7. PubMed ID: 7853190
    [Abstract] [Full Text] [Related]

  • 7. Elucidation of the insurmountable nature of an angiotensin receptor antagonist, SC-54629.
    Olins GM, Chen ST, McMahon EG, Palomo MA, Reitz DB.
    Mol Pharmacol; 1995 Jan; 47(1):115-20. PubMed ID: 7838120
    [Abstract] [Full Text] [Related]

  • 8. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [Abstract] [Full Text] [Related]

  • 9. Nonpeptide angiotensin II receptor antagonists. VII. Cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent.
    Chiu AT, McCall DE, Price WA, Wong PC, Carini DJ, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):711-8. PubMed ID: 2313596
    [Abstract] [Full Text] [Related]

  • 10. Effects of SC-52458, an angiotensin AT1 receptor antagonist, in the dog.
    McMahon EG, Yang PC, Babler MA, Suleymanov OD, Palomo MA, Olins GM, Cook CS.
    Am J Hypertens; 1997 Jun; 10(6):671-7. PubMed ID: 9194514
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic characterization of CI-996, a new angiotensin receptor antagonist.
    Keiser JA, Ryan MJ, Panek RL, Hodges JC, Sircar I.
    J Pharmacol Exp Ther; 1995 Mar; 272(3):963-9. PubMed ID: 7891350
    [Abstract] [Full Text] [Related]

  • 12. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):719-25. PubMed ID: 2179531
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K.
    J Pharmacol Exp Ther; 1993 Jul; 266(1):114-20. PubMed ID: 8331552
    [Abstract] [Full Text] [Related]

  • 15. Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2).
    Wong PC, Hart SD, Zaspel AM, Chiu AT, Ardecky RJ, Smith RD, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Nov; 255(2):584-92. PubMed ID: 2243344
    [Abstract] [Full Text] [Related]

  • 16. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):211-7. PubMed ID: 2213556
    [Abstract] [Full Text] [Related]

  • 17. EXP063, a nonpeptide angiotensin II and beta adrenergic receptor antagonist.
    Wong PC, Duncia JV, Chiu AT, Olson RE, Rominger DH, Tam SW, Timmermans PB.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):641-7. PubMed ID: 7902431
    [Abstract] [Full Text] [Related]

  • 18. Pharmacological characterization of SR 47436, a new nonpeptide AT1 subtype angiotensin II receptor antagonist.
    Cazaubon C, Gougat J, Bousquet F, Guiraudou P, Gayraud R, Lacour C, Roccon A, Galindo G, Barthelemy G, Gautret B.
    J Pharmacol Exp Ther; 1993 May; 265(2):826-34. PubMed ID: 8496828
    [Abstract] [Full Text] [Related]

  • 19. Effects of the new angiotensin II type 1 receptor antagonist KRH-594 on several types of experimental hypertension.
    Inada Y, Murakami M, Kaido K, Nakao K.
    Arzneimittelforschung; 1999 Jan; 49(1):13-21. PubMed ID: 10028373
    [Abstract] [Full Text] [Related]

  • 20. In vivo pharmacology of L-158,809, a new highly potent and selective nonpeptide angiotensin II receptor antagonist.
    Siegl PK, Chang RS, Mantlo NB, Chakravarty PK, Ondeyka DL, Greenlee WJ, Patchett AA, Sweet CS, Lotti VJ.
    J Pharmacol Exp Ther; 1992 Jul; 262(1):139-44. PubMed ID: 1625193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.